🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Holly A. Hill

The University of Texas MD Anderson Cancer Center

ORCID: 0000-0003-3642-1897

Also affiliated with National Center for Immunization and Respiratory Diseases

MedicineComputer ScienceSocial SciencesMathematics

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

2in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Data from Integrative Prognostic Machine-Learning Models in Mantle Cell Lymphoma

(2023)10.1158/2767-9764.c.6736333.v1
Top 100%
0DataRank
Top 100%0 citations

Preetesh Jain, Chi Young Ok, Koji Sasaki, Han Chen, Michael Wang +2 more

Papers

Driven by 14 papers — median percentile 0. Top paper: “Ibrutinib With Rituximab in First-Line Treatment of Older Patients With Mantle Cell Lymphoma”.

Ibrutinib With Rituximab in First-Line Treatment of Older Patients With Mantle Cell Lymphoma

Journal of Clinical Oncology(2021)10.1200/jco.21.01797
N/A
2.5DataRank · unranked
83 citations

Shuangtao Zhao, Hun Ju Lee, Holly A. Hill, Chi Young Ok, Rashmi Kanagal‐Shamanna +22 more

Ibrutinib–rituximab followed by R-HCVAD as frontline treatment for young patients (≤65 years) with mantle cell lymphoma (WINDOW-1): a single-arm, phase 2 trial

The Lancet Oncology(2022)10.1016/s1470-2045(21)00638-0
N/A
1.5DataRank · unranked
56 citations

Preetesh Jain, Shuangtao Zhao, Hun Ju Lee, Loretta J. Nastoupil, Luis Fayad +32 more

Changes in vaccine hesitancy among parents of children aged 6 months – 17 Years, National Immunization Surveys, 2019–2022

Vaccine(2024)10.1016/j.vaccine.2024.05.037
N/A
0.483DataRank · unranked
24 citations

David Yankey, Laurie D. Elam–Evans, Yi Mu, Madeleine R. Valier, Cassandra Pingali +4 more

Immune-depleted tumor microenvironment is associated with poor outcomes and BTK inhibitor resistance in mantle cell lymphoma

Blood Cancer Journal(2023)10.1038/s41408-023-00927-2
N/A
0.425DataRank · unranked
16 citations

Krystle Nomie, Nikita Kotlov, VitaIy Segodin, Holly A. Hill, Chi Young Ok +8 more

Six Years Follow up of Ibrutinib Plus Rituximab (IR) Followed By Short Course R-Hyper CVAD/MTX in Patients (age ≤ 65 years) with Previously Untreated Mantle Cell Lymphoma - Phase-II Window-1 Clinical Trial

Blood(2023)10.1182/blood-2023-181312
N/A
0DataRank · unranked
1 citations

Hun Ju Lee, Jason R. Westin, Loretta J. Nastoupil, Luis Fayad, Ranjit Nair +14 more

Data from Integrative Prognostic Machine-Learning Models in Mantle Cell Lymphoma

(2023)10.1158/2767-9764.c.6736333.v1
Top 100%
0DataRank
Top 100%0 citations

Preetesh Jain, Chi Young Ok, Koji Sasaki, Han Chen, Michael Wang +2 more

Data from Integrative Prognostic Machine Learning Models in Mantle Cell Lymphoma

(2023)10.1158/2767-9764.c.6736333
Top 100%
0DataRank
Top 100%0 citations

Preetesh Jain, Chi Young Ok, Koji Sasaki, Han Chen, Michael Wang +2 more

Genomic and Transcriptomic Profiles of Blastoid and Pleomorphic Mantle Cell Lymphoma Are Distinct from Classic Histology Mantle Cell Lymphoma

Blood(2023)10.1182/blood-2023-181319
N/A
0DataRank · unranked
0 citations

Holly A. Hill, Chi Young Ok, Alexander Nesmalov, Vitaly Segodin, Dmitry Tabakov +13 more

BST2 facilitates activation of hematopoietic stem cells through ERK signaling

Experimental Hematology(2024)10.1016/j.exphem.2024.104653
N/A
0DataRank · unranked
3 citations

Apoorva Thatavarty, Duy T. Le, Holly A. Hill, Youngjae Jeong, Brian M. Ho +7 more

Acalabrutinib with Rituximab Is Highly Effective First Line Treatment for Older Patients with Mantle Cell Lymphoma

Blood(2024)10.1182/blood-2024-206042
N/A
0DataRank · unranked
1 citations

Chi Young Ok, Jason R. Westin, Holly A. Hill, Ranjit Nair, Swaminathan P. Iyer +28 more

Integrative profiling strategies to guide personalized therapy in mantle cell lymphoma: a pilot study

npj Precision Oncology(2025)10.1038/s41698-025-01158-3
N/A
0DataRank · unranked
0 citations

Holly A. Hill, Yijing Li, Joseph McIntosh, Changying Jiang, Fangfang Yan +9 more

Longitudinal single-cell profiling reveals molecular heterogeneity and tumor-immune evolution in refractory mantle cell lymphoma

Nature Communications(2021)10.1038/s41467-021-22872-z
N/A
0DataRank · unranked
68 citations

Changying Jiang, Guangchun Han, Dapeng Hao, Junwei Lian, Yang Liu +33 more

Vaccination Coverage of Privately Insured Children: Comparing U.S. Survey and Administrative Data

American Journal of Preventive Medicine(2022)10.1016/j.amepre.2022.01.020
N/A
0DataRank · unranked
1 citations

Holly A. Hill, Yuping Tsai, Megan C. Lindley, Fangjun Zhou, Kai Hong

Integrative Prognostic Machine Learning Models in Mantle Cell Lymphoma

Cancer Research Communications(2023)10.1158/2767-9764.crc-23-0083
N/A
0DataRank · unranked
6 citations

Preetesh Jain, Chi Young Ok, Koji Sasaki, Han Chen, Michael Wang +2 more